All In Biotech

Drug Trial Radar · NCT06803823

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

A Phase 2a, Multicenter, Placebo-controlled, Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Last checked: Nov 19, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

May 1, 2025

Primary completion

Dec 31, 2026

Study completion Mar 31, 2027

Sponsor

Lead sponsor
Ono Pharmaceutical Co., Ltd.Industry
Sponsor type
Industry
First posted
Jan 31, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 55 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.

Conditions

  • Agitation Associated With Alzheimer's Disease Dementia

Interventions

  • ONO-2020Drug

    ONO-2020 group: Two ONO-2020 tablets will be orally administered once daily.

  • PlaceboDrug

    Two ONO-2020 placebo tablets will be orally administered once daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in CMAI score from baselineTime frame: up to week 12
  2. Adverse eventsTime frame: up to week 16
  3. Body weightTime frame: up to week 16
  4. Body temperatureTime frame: up to week 16
  5. Blood pressureTime frame: up to week 16
  6. Pulse rateTime frame: up to week 16
  7. Respiratory rateTime frame: up to week 16
  8. ECG RR intervalTime frame: up to week 12
  9. ECG PR intervalTime frame: up to week 12
  10. ECG QRS complexTime frame: up to week 12
  11. ECG QT intervalTime frame: up to week 12
  12. ECG QTcFTime frame: up to week 12
  13. Number of participants with abnormal laboratory tests (hematology)Time frame: up to week 12
  14. Number of participants with abnormal laboratory tests (Clinical chemistry)Time frame: up to week 12
  15. Number of participants with abnormal Blood coagulation profile (Activated partial thromboplastin time (APTT), Prothrombin time (PT), International normalized ratio (INR))Time frame: up to week 12
  16. Number of participants with abnormal UrinalysisTime frame: up to week 12
  17. COLUMBIA-SUICIDE SEVERITY RATING SCALE(C-SSRS)Time frame: up to week 16

Locations

39 sites in 1 country. Site status is shown where the registry gives one.

  • Hotei Hospital

    Aichi, Japan · Recruiting

  • Akita Prefectural Center For Rehabilitation and Psychiatric Medicine

    Akita, Japan · Recruiting

  • Medical Corporation Keishinkai Kyowa Hospital

    Akita, Japan · Recruiting

  • Aiseikai General Incorporated Foundation, Hirosaki Aiseikai Hospital

    Aomori, Japan · Recruiting

  • Seinan Hospital

    Aomori, Japan · Recruiting

  • Fukui Hospital

    Fukui, Japan · Recruiting

  • Matsubara Hospital

    Fukui, Japan · Recruiting

  • Aburayama Hospital

    Fukuoka, Japan · Recruiting

  • Kuramitsu Hospital

    Fukuoka, Japan · Recruiting

  • Kishikai Kishi Hospital

    Gunma, Japan · Recruiting

  • Hayakawa Clinic

    Hiroshima, Japan · Recruiting

  • Koseikai Cocoro Hospital Kusatsu

    Hiroshima, Japan · Recruiting

  • Nakamura Hospital

    Hiroshima, Japan · Recruiting

  • Keiseikai Hospital

    Hokkaido, Japan · Recruiting

  • NHO Obihiro National Hospital

    Hokkaido, Japan · Recruiting

  • Airanomori Hospital

    Kagoshima, Japan · Recruiting

  • Ishiki Hospital

    Kagoshima, Japan · Recruiting

  • Sansyu Hospital

    Kagoshima, Japan · Recruiting

  • Taniyama Hospital

    Kagoshima, Japan · Recruiting

  • Fujisawahospital

    Kanagawa, Japan · Recruiting

  • Hatano Kousei Hospital

    Kanagawa, Japan · Recruiting

  • Showa Medical University Northern Yokohama Hospital

    Kanagawa, Japan · Recruiting

  • Hosogi Hospital

    Kochi, Japan · Recruiting

  • Ichiyo Mental Hospital

    Kochi, Japan · Terminated

  • Maizuru Medical Center

    Kyoto, Japan · Recruiting

  • Nishiyama Hospital

    Kyoto, Japan · Recruiting

  • Iryohojin Shadan Shoshinkai Morinohosupitaru・Aoba

    Miyagi, Japan · Recruiting

  • JA-Nagano North Alps Medical Center Azumi Hospital

    Nagano, Japan · Recruiting

  • Jizenkai Ando Hospital

    Nagano, Japan · Recruiting

  • Nara Medical University Hospital

    Nara, Japan · Recruiting

  • Nagaokai Neyagawa Sanatorium

    Osaka, Japan · Recruiting

  • Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital

    Osaka, Japan · Recruiting

  • Osaka Psychiatric Medical Center

    Osaka, Japan · Recruiting

  • Hizen Psychiatric Center

    Saga, Japan · Recruiting

  • Rainbow & Sea Hospital

    Saga, Japan · Recruiting

  • Saitama Konan Hospital

    Saitama, Japan · Recruiting

  • Asuka Hospital

    Tokyo, Japan · Terminated

  • Nishigahara Hospital

    Tokyo, Japan · Terminated

  • Sanyokai Sanyo Hospital

    Yamagata, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.